Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone and pergolide for cognitive deficits in schizophrenia
ISRCTN42412532Phase 4Completed
- Sponsor
- RWTH Aachen University
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Tolcapone, Pergolide and Placebo (3 arms). Primary endpoint: Change in MATRICS Consensus Cognitive Battery. Started Apr 2010; status: completed.
02
Drugs
tolcaponepergolide
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ISRCTN42412532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN42412532.